In AAV gene therapy, safety isn't optional-it's everything. That's why we're proud to introduce a powerful new tool to your immunogenicity toolkit: the AAV Complement Activation Assay.
This assay is the first of its kind available on the market, giving you a critical edge in detecting and managing immune responses that could compromise patient safety and therapeutic success.